Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

510 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized controlled phase III study comparing chemotherapy alone versus conversion surgery after a remarkable response to chemotherapy in patients with initially unresectable cStage IVB or pStage IV gastric cancer (JCOG2301, Conversion study).
Kita R, Yasufuku I, Takahashi N, Mizusawa J, Sano Y, Fukuda H, Kurokawa Y, Boku N, Terashima M, Yoshikawa T; Stomach Cancer Study Group of the Japan Clinical Oncology Group. Kita R, et al. Among authors: boku n. Jpn J Clin Oncol. 2024 Dec 18:hyae174. doi: 10.1093/jjco/hyae174. Online ahead of print. Jpn J Clin Oncol. 2024. PMID: 39690810
A Phase II study of systemic chemotherapy with docetaxel, cisplatin, and S-1 (DCS) followed by surgery in gastric cancer patients with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1002.
Katayama H, Ito S, Sano T, Takahari D, Mizusawa J, Boku N, Tsuburaya A, Terashima M, Sasako M; Stomach Cancer Study Group of the Japan Clinical Oncology Group. Katayama H, et al. Among authors: boku n. Jpn J Clin Oncol. 2012 Jun;42(6):556-9. doi: 10.1093/jjco/hys054. Epub 2012 Apr 23. Jpn J Clin Oncol. 2012. PMID: 22525210 Clinical Trial.
A randomized Phase II trial of systemic chemotherapy with and without trastuzumab followed by surgery in HER2-positive advanced gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301 (Trigger Study).
Kataoka K, Tokunaga M, Mizusawa J, Machida N, Katayama H, Shitara K, Tomita T, Nakamura K, Boku N, Sano T, Terashima M, Sasako M; Stomach Cancer Study Group/Japan Clinical Oncology Group. Kataoka K, et al. Among authors: boku n. Jpn J Clin Oncol. 2015 Nov;45(11):1082-6. doi: 10.1093/jjco/hyv134. Epub 2015 Sep 9. Jpn J Clin Oncol. 2015. PMID: 26355164 Clinical Trial.
A phase III trial to confirm modified S-1 adjuvant chemotherapy for pathological stage II/III vulnerable elderly gastric cancer patients who underwent gastric resection (JCOG1507, BIRDIE).
Mizutani T, Yamaguchi K, Mizusawa J, Ito S, Nishida Y, Yabusaki H, Boku N, Sano T, Yoshida K, Sasako M, Yoshikawa T, Terashima M; Stomach Cancer Study Group/Japan Clinical Oncology Group. Mizutani T, et al. Among authors: boku n. Jpn J Clin Oncol. 2018 Dec 1;48(12):1101-1104. doi: 10.1093/jjco/hyy152. Jpn J Clin Oncol. 2018. PMID: 30346560 Clinical Trial.
Randomized controlled Phase III trial to evaluate omentum preserving gastrectomy for patients with advanced gastric cancer (JCOG1711, ROAD-GC).
Sato Y, Yamada T, Yoshikawa T, Machida R, Mizusawa J, Katayama H, Tokunaga M, Boku N, Terashima M; Stomach Cancer Study Group/Japan Clinical Oncology Group. Sato Y, et al. Among authors: boku n. Jpn J Clin Oncol. 2020 Oct 22;50(11):1321-1324. doi: 10.1093/jjco/hyaa113. Jpn J Clin Oncol. 2020. PMID: 32638017 Clinical Trial.
Current status of immunotherapy for advanced gastric cancer.
Kawazoe A, Shitara K, Boku N, Yoshikawa T, Terashima M. Kawazoe A, et al. Among authors: boku n. Jpn J Clin Oncol. 2021 Jan 1;51(1):20-27. doi: 10.1093/jjco/hyaa202. Jpn J Clin Oncol. 2021. PMID: 33241322 Review.
Randomized phase II study comparing neoadjuvant 5-fluorouracil/oxaliplatin/docetaxel versus docetaxel/oxaliplatin/S-1 for patients with type 4 or large type 3 gastric cancer.
Hashimoto T, Nakayama I, Ohashi M, Mizusawa J, Kawachi H, Kita R, Fukuda H, Kurokawa Y, Boku N, Yoshikawa T, Terashima M. Hashimoto T, et al. Among authors: boku n. Future Oncol. 2023 Oct;19(32):2147-2155. doi: 10.2217/fon-2023-0605. Epub 2023 Oct 26. Future Oncol. 2023. PMID: 37882373
Protocol digest of a randomized controlled adaptive Phase II/III trial of neoadjuvant chemotherapy for Japanese patients with oesophagogastric junction adenocarcinoma: Japan Clinical Oncology Group Study JCOG2203 (NEO-JPEG).
Kita R, Yanagimoto Y, Imazeki H, Booka E, Tsushima T, Mizusawa J, Sasaki K, Fukuda H, Kurokawa Y, Takeuchi H, Kato K, Kitagawa Y, Boku N, Yoshikawa T, Terashima M; Stomach Cancer Study Group and Japan Esophageal Oncology Group of the Japan Clinical Oncology Group. Kita R, et al. Among authors: boku n. Jpn J Clin Oncol. 2024 Feb 7;54(2):206-211. doi: 10.1093/jjco/hyad149. Jpn J Clin Oncol. 2024. PMID: 37952093
510 results